Eric Joseph
Stock Analyst at Citi
(4.34)
# 1,369
Out of 5,133 analysts
350
Total ratings
50.2%
Success rate
8.8%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $320 → $250 | $165.04 | +51.48% | 8 | Nov 10, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $100 | $29.06 | +244.12% | 8 | Nov 9, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $50 | $34.33 | +45.65% | 3 | Nov 9, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $99 → $105 | $56.13 | +87.07% | 4 | Nov 6, 2026 | |
| MDGL Madrigal Pharmaceuticals | Reiterated: Buy | $725 → $760 | $427.39 | +77.82% | 2 | Nov 4, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $76 | $57.23 | +32.80% | 7 | Nov 2, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $108 → $109 | $63.49 | +71.68% | 32 | Nov 2, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Hold | $91 | $78.30 | +16.22% | 7 | Oct 30, 2026 | |
| ASND Ascendis Pharma | Reiterated: Buy | $360 → $330 | $275.39 | +19.83% | 3 | Oct 26, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $108 | $47.78 | +126.04% | 3 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 → $49 | $64.51 | n/a | 18 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.697 | n/a | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $22.83 | n/a | 20 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $64 | $127.57 | n/a | 11 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $44 → $7 | $2.30 | n/a | 20 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $8.53 | n/a | 23 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.27 | n/a | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $18 | $3.80 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.60 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $11 | $18.09 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $9.96 | n/a | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.68 | n/a | 1 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $12 | $9.37 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $21 | $3.13 | n/a | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 → $70 | $172.29 | n/a | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $9 → $5 | $10.99 | n/a | 13 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $30 | $15.48 | n/a | 11 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $0.5822 | n/a | 11 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $7 | $2.76 | n/a | 6 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 → $10 | $3.19 | n/a | 6 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $5 | $1.65 | n/a | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $5 | $14.30 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $4.30 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $1.17 | n/a | 4 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $31.61 | n/a | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $2.10 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $13 | $4.83 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $7 | $1.47 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $0.4742 | n/a | 5 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 → $11 | $7.57 | n/a | 3 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $17.49 | n/a | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.000001 | n/a | 3 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $39 → $26 | $26.18 | n/a | 3 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.54 | n/a | 1 | Feb 7, 2020 |
Alnylam Pharmaceuticals
Nov 10, 2026
Reiterated: Buy
Price Target: $320 → $250
Current: $165.04
Upside: +51.48%
Ionis Pharmaceuticals
Nov 9, 2026
Reiterated: Buy
Price Target: $100
Current: $29.06
Upside: +244.12%
Maze Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $50
Current: $34.33
Upside: +45.65%
Cytokinetics
Nov 6, 2026
Reiterated: Buy
Price Target: $99 → $105
Current: $56.13
Upside: +87.07%
Madrigal Pharmaceuticals
Nov 4, 2026
Reiterated: Buy
Price Target: $725 → $760
Current: $427.39
Upside: +77.82%
BioMarin Pharmaceutical
Nov 2, 2026
Reiterated: Buy
Price Target: $76
Current: $57.23
Upside: +32.80%
PTC Therapeutics
Nov 2, 2026
Reiterated: Buy
Price Target: $108 → $109
Current: $63.49
Upside: +71.68%
BridgeBio Pharma
Oct 30, 2026
Reiterated: Hold
Price Target: $91
Current: $78.30
Upside: +16.22%
Ascendis Pharma
Oct 26, 2026
Reiterated: Buy
Price Target: $360 → $330
Current: $275.39
Upside: +19.83%
Arrowhead Pharmaceuticals
Oct 14, 2026
Reiterated: Buy
Price Target: $108
Current: $47.78
Upside: +126.04%
Nov 3, 2025
Reiterated: Buy
Price Target: $46 → $49
Current: $64.51
Upside: n/a
Oct 10, 2025
Downgraded: Sell
Price Target: n/a
Current: $0.697
Upside: n/a
Jun 25, 2025
Reiterated: Buy
Price Target: $48
Current: $22.83
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: $57 → $64
Current: $127.57
Upside: n/a
May 28, 2025
Downgraded: Hold
Price Target: $44 → $7
Current: $2.30
Upside: n/a
May 19, 2025
Reiterated: Sell
Price Target: $7
Current: $8.53
Upside: n/a
May 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $4.27
Upside: n/a
May 16, 2025
Reiterated: Buy
Price Target: $22 → $18
Current: $3.80
Upside: n/a
May 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $42.60
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $21 → $11
Current: $18.09
Upside: n/a
May 7, 2025
Reiterated: Hold
Price Target: $14
Current: $9.96
Upside: n/a
Apr 25, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.68
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $15 → $12
Current: $9.37
Upside: n/a
Mar 4, 2025
Reiterated: Buy
Price Target: $20 → $21
Current: $3.13
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $71 → $70
Current: $172.29
Upside: n/a
Feb 10, 2025
Reiterated: Sell
Price Target: $9 → $5
Current: $10.99
Upside: n/a
Jan 29, 2025
Reiterated: Buy
Price Target: $31 → $30
Current: $15.48
Upside: n/a
Dec 17, 2024
Reiterated: Hold
Price Target: $11
Current: $0.5822
Upside: n/a
Feb 23, 2024
Reiterated: Hold
Price Target: $6 → $7
Current: $2.76
Upside: n/a
Nov 13, 2023
Reiterated: Hold
Price Target: $11 → $10
Current: $3.19
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $28 → $5
Current: $1.65
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $15 → $5
Current: $14.30
Upside: n/a
Aug 10, 2023
Downgraded: Sell
Price Target: n/a
Current: $4.30
Upside: n/a
May 5, 2023
Reiterated: Hold
Price Target: $6 → $5
Current: $1.17
Upside: n/a
Nov 29, 2022
Downgraded: Sell
Price Target: n/a
Current: $31.61
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $2.10
Upside: n/a
May 5, 2022
Reiterated: Hold
Price Target: $12 → $13
Current: $4.83
Upside: n/a
Mar 29, 2022
Reiterated: Buy
Price Target: $24 → $7
Current: $1.47
Upside: n/a
Mar 4, 2022
Reiterated: Sell
Price Target: n/a
Current: $0.4742
Upside: n/a
Nov 11, 2021
Reiterated: Hold
Price Target: $14 → $11
Current: $7.57
Upside: n/a
Oct 8, 2021
Downgraded: Sell
Price Target: n/a
Current: $17.49
Upside: n/a
Nov 9, 2020
Downgraded: Sell
Price Target: n/a
Current: $0.000001
Upside: n/a
Sep 21, 2020
Reiterated: Hold
Price Target: $39 → $26
Current: $26.18
Upside: n/a
Feb 7, 2020
Reiterated: Hold
Price Target: n/a
Current: $4.54
Upside: n/a